Evidence map›Paper›PMID 22290119›Full record

ArticleMolecular psychiatry2013

Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety.

K S Sink, D L Walker, S M Freeman, E I Flandreau, K J Ressler, M Davis

Open access · bronzeAbstract read
In one paragraph

Article in Molecular psychiatry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 109 citations in OpenAlex.

  1. The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Trial
  2. Fine mapping of PTSD GWAS reveals a role for amygdalabioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. 5-HTBrain sciences · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

K S SinkDepartment of Psychiatry and Behavioral Sciences, Yerkes National Primate Center, Emory University, Atlanta, GA 30329, USA. ksink@emory.edu
D L Walker
S M Freeman
E I Flandreau
K J Ressler
M Davis
Emory University · US

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI JOHNS, MICHAEL M · 1985 to 2011
$114.0M
Projevt 5: Effects of the CRF1 receptor antagonist in patients w/PTSD: a plcebocoU19MH069056 · NIMH · EMORY UNIVERSITY · PI ROTHBAUM, BARBARA O · 2003 to 2013
$15.4M
ENNCF - Viral Vector CoreP30NS055077 · NINDS · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2008 to 2018
$6.8M
ANATOMY AND PHARMACOLOGY OF FEAR-POTENTIATED STARTLER37MH047840 · NIMH · YALE UNIVERSITY · PI DAVIS, MICHAEL NMN · 1991 to 2010
$3.6M
Neural Substrates of Phasic versus Sustained FearR01MH080330 · NIMH · EMORY UNIVERSITY · PI WALKER, DAVID · 2010 to 2014
$1.9M
Anatomy and Pharmacology of Fear-Potentiated StartleR01MH047840 · NIMH · EMORY UNIVERSITY · PI WALKER, DAVID · 2011 to 2011
$418k
The role of BNST CGRP in stress-enhanced anxiety behavior and HPA-axis functionF32MH093023 · NIMH · EMORY UNIVERSITY · PI SINK, KELLY S. · 2010 to 2012
$107k
NCRR NIH HHS 2P51RR000165-51NCRR NIH HHS P51 RR000165NIMH NIH HHS F32 MH093023NIMH NIH HHS MH069056NIMH NIH HHS MH080330NIMH NIH HHS MH093023NIMH NIH HHS MH47840NIMH NIH HHS R01 MH047840NIMH NIH HHS R01 MH080330NIMH NIH HHS R37 MH047840NIMH NIH HHS U19 MH069056NINDS NIH HHS P30 NS055077NINDS NIH HHS P30NS055077
6 · The paper itself

Abstract

The lateral division of the bed nucleus of the stria terminalis (BNST), which forms part of the circuitry regulating fear and anxiety, contains a large number of neurons expressing corticotropin releasing factor (CRF), a neuropeptide that has a prominent role in the etiology of fear- and anxiety-related psychopathologies. Stress increases CRF expression within BNST neurons, implicating these cells in stress- and anxiety-related behaviors. These experiments examined the effect of chronically enhanced CRF expression within BNST neurons on conditioned and unconditioned anxiety-related behavior by using a lentiviral vector containing a promoter that targets CRF gene overexpression (OE) to CRFergic cells. We found that BNST CRF-OE did not affect unconditioned anxiety-like responses in the elevated plus maze or basal acoustic startle amplitude. CRF-OE induced before training weakened sustained fear (conditioned anxiety); when induced after conditioning, CRF-OE increased expression of the conditioned emotional memory. Increased BNST CRF expression did not affect plasma corticosterone concentration but did decrease CRFR1 receptor density within the BNST and CRFR2 receptor density within the dorsal portion of the caudal dorsal raphe nucleus. These data raise the possibility that the observed behavioral effects may be mediated by enhanced CRF receptor signaling or compensatory changes in CRF receptor density within these structures. Together, these studies demonstrate that CRF neurons within the lateral BNST modulate conditioned anxiety-like behaviors and also suggest that enhanced CRF expression within these neurons may contribute to inappropriate regulation of emotional memories.

Indexed as

AnimalsAnxietyConditioning, PsychologicalCorticosteroneCorticotropin-Releasing HormoneCRF Receptor, Type 1MaleNeuronsRaphe NucleiRatsReceptors, Corticotropin-Releasing HormoneSeptal NucleiCorticosteroneCorticotropin-Releasing HormoneCRF Receptor, Type 1CRF receptor type 2Receptors, Corticotropin-Releasing Hormone

Identifiers

PMID22290119
PMCPMC3578178
OpenAlexW2077792190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.